美股市場個股詳情

HOWL Werewolf Therapeutics

添加自選

5.480
-0.240-4.20%

收盤價 05/08 16:00 (美東)

5.340
-0.140-2.55%

盤後 16:07 (美東)

2.38億總市值-4981市盈率TTM

Werewolf Therapeutics股票討論區

登錄發表評論

Trytosaveabit

05/03 19:16

Reminder to make a note!

$Werewolf Therapeutics(HOWL.US)$ Werewolf Therapeutics Inc: Plans to Present Interim, First-in-Human Clinical Data From Ongoing Phase 1 Trial of Wtx-330 in Q2 of 2024

Trytosaveabit

04/14 20:01

Watching! Lots of information coming before EO2Q!

$Werewolf Therapeutics(HOWL.US)$ Upcoming Milestones! Most if not all data of some sort is to be released before end of Q2!
WTX-124:
•In the first half of 2024, Werewolf expects to present additional interim dose-escalation data from the monotherapy dose-escalation arm, nominate a recommended dose for expansion and initiate monotherapy dose expansion arms.
•Additionally, Werewolf continues to progress combination dose escalation cohorts of the Ph...

Moomoo AI

01/30 18:09

Despite Werewolf Therapeutics' stock surge, its modest P/S ratio is justified due to inconsistent revenue growth and forecasted contraction. The weak outlook could continue to impact the share price.

Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) Shares Bounce 27% But Its Business Still Trails The Industry

Moomoo AI

01/05 05:13

Dr. Atkins sees great potential in Werewolf Therapeutics' immunotherapies for cancer treatment. Werewolf Therapeutics' CEO appreciates Atkins' expertise as the company grows.

Press Release: Werewolf Therapeutics Appoints Michael Atkins, M.D., to Its Board of Directors

Moomoo AI

2023/12/09 20:30

Werewolf Therapeutics' revenue performance is uncertain, and it's P/S ratio is low compared to the biotech industry due to potential shrink in revenues. Its low P/S ratio is justified given other companies' revenue growth forecasts, indicating no significant share price rise.

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Held Back By Insufficient Growth Even After Shares Climb 28%

夜轻歌

2023/11/21 07:26

$Werewolf Therapeutics(HOWL.US)$ 站上Ma 20均線了上升趨勢中

已翻譯

Trytosaveabit

2023/11/15 06:35

Nice!

$Werewolf Therapeutics(HOWL.US)$ Werewolf Therapeutics Q3 2023 EPS $(0.23) Up From $(0.40) Revenue $5.897M Beats $1.592M Estimate

SlowndEasyTrades

2023/11/04 11:01

$Werewolf Therapeutics(HOWL.US)$ 👀werewolf in action now with massive buying volume today 🤣 lets hope its not spam in for few small postion

wooper

2023/11/03 21:35

I like pstv only

📈💥 Let's seize Friday! Yesterday we witnessed a ticker surge with a 44.24% LONG MOVE. Today's focus:
✅1️⃣ HOWL Long > 2.73 Short < 2.61
✅2️⃣ NVOS Long > 0.3300 Short < 0.3095
✅3️⃣ CYTO Long > 0.2035 Short < 0.1855
✅4️⃣ PSTV Long > 1.64 Short < 1.49
✅5️⃣ IFRX Long > 1.62 Short < 1.53
✅6️⃣ FUBO Long > 3.20 Short < 2.99

Be a voice no echo

2023/11/03 20:37

3.34

$Werewolf Therapeutics(HOWL.US)$

暫無評論

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

美股

綜合熱度